Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 227

1.

A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.

Yang M, Nonaka D.

Mod Pathol. 2010 May;23(5):654-61. doi: 10.1038/modpathol.2010.38. Epub 2010 Feb 19.

PMID:
20173733
[PubMed - indexed for MEDLINE]
Free Article
2.

GCDFP-15 positive and TTF-1 negative primary lung neoplasms: a tissue microarray study of 381 primary lung tumors.

Wang LJ, Greaves WO, Sabo E, Noble L, Tavares R, Ng T, DeLellis RA, Resnick MB.

Appl Immunohistochem Mol Morphol. 2009 Dec;17(6):505-11. doi: 10.1097/PAI.0b013e3181a8e809.

PMID:
19620839
[PubMed - indexed for MEDLINE]
3.

Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.

Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT.

Cancer. 2001 Oct 25;93(5):330-6.

PMID:
11668468
[PubMed - indexed for MEDLINE]
4.

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.

Bishop JA, Sharma R, Illei PB.

Hum Pathol. 2010 Jan;41(1):20-5. doi: 10.1016/j.humpath.2009.06.014. Epub 2009 Sep 8.

PMID:
19740516
[PubMed - indexed for MEDLINE]
5.

Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.

Ye J, Findeis-Hosey JJ, Yang Q, McMahon LA, Yao JL, Li F, Xu H.

Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):313-7. doi: 10.1097/PAI.0b013e318205b059.

PMID:
21464700
[PubMed - indexed for MEDLINE]
6.

Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers.

Sasaki E, Tsunoda N, Hatanaka Y, Mori N, Iwata H, Yatabe Y.

Mod Pathol. 2007 Feb;20(2):208-14. Epub 2006 Dec 22.

PMID:
17192791
[PubMed - indexed for MEDLINE]
Free Article
7.

[Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].

Zou SM, Lin DM, Lü N, Liu XY, Wen P, Liu FS.

Zhonghua Yi Xue Za Zhi. 2003 Aug 10;83(15):1350-2. Chinese.

PMID:
12930693
[PubMed - indexed for MEDLINE]
8.

Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor.

Gomez-Fernandez C, Mejias A, Walker G, Nadji M.

Appl Immunohistochem Mol Morphol. 2010 Mar;18(2):137-41. doi: 10.1097/PAI.0b013e3181bec23b.

PMID:
19875957
[PubMed - indexed for MEDLINE]
9.

Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.

Zamecnik J, Kodet R.

Virchows Arch. 2002 Apr;440(4):353-61. Epub 2001 Oct 19.

PMID:
11956814
[PubMed - indexed for MEDLINE]
10.

Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.

Su YC, Hsu YC, Chai CY.

Kaohsiung J Med Sci. 2006 Jan;22(1):14-9.

PMID:
16570563
[PubMed - indexed for MEDLINE]
11.

Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.

Dejmek A, Naucler P, Smedjeback A, Kato H, Maeda M, Yashima K, Maeda J, Hirano T.

Diagn Cytopathol. 2007 Aug;35(8):493-7.

PMID:
17636482
[PubMed - indexed for MEDLINE]
12.
13.

Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas.

Mukhopadhyay S, Katzenstein AL.

Am J Clin Pathol. 2012 Nov;138(5):703-11. doi: 10.1309/AJCPKVBXTI9O3TEM.

PMID:
23086771
[PubMed - indexed for MEDLINE]
Free Article
14.

Immunohistochemical expression of estrogen receptor in pulmonary adenocarcinoma.

Lau SK, Chu PG, Weiss LM.

Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):83-7.

PMID:
16540736
[PubMed - indexed for MEDLINE]
15.

Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.

Kadivar M, Boozari B.

Appl Immunohistochem Mol Morphol. 2013 May;21(3):191-5. doi: 10.1097/PAI.0b013e3182612643.

PMID:
22914608
[PubMed - indexed for MEDLINE]
16.

Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma.

Harlamert HA, Mira J, Bejarano PA, Baughman RP, Miller MA, Whitsett JA, Yassin R.

Acta Cytol. 1998 Nov-Dec;42(6):1382-8.

PMID:
9850647
[PubMed - indexed for MEDLINE]
17.

Expression of bcl-2 by breast cancer: a possible diagnostic application.

Alsabeh R, Wilson CS, Ahn CW, Vasef MA, Battifora H.

Mod Pathol. 1996 Apr;9(4):439-44.

PMID:
8729986
[PubMed - indexed for MEDLINE]
18.

Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.

Ye J, Hameed O, Findeis-Hosey JJ, Fan L, Li F, McMahon LA, Yang Q, Wang HL, Xu H.

Biotech Histochem. 2012 Jan;87(1):30-4. doi: 10.3109/10520295.2011.591838. Epub 2011 Aug 15.

PMID:
21838611
[PubMed - indexed for MEDLINE]
19.

Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.

Bejarano PA, Baughman RP, Biddinger PW, Miller MA, Fenoglio-Preiser C, al-Kafaji B, Di Lauro R, Whitsett JA.

Mod Pathol. 1996 Apr;9(4):445-52.

PMID:
8729987
[PubMed - indexed for MEDLINE]
20.

Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.

Ueno T, Linder S, Elmberger G.

Br J Cancer. 2003 Apr 22;88(8):1229-33.

PMID:
12698189
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk